drug screening Joint Venture From SEngine, Gustave Roussy Aims to Commercialize Cancer Dx Test Across Europe Premium SEngine's PARIS test combines high-throughput drug screening of live, patient-derived tumor cells with DNA sequencing and data analysis. Broad Institute DepMap Project Could Lead to Development of New Cancer Drugs Premium At the Association for Molecular Pathology annual meeting, cancer researcher William Hahn talked about efforts to map cancer fitness genes at the genome scale. Singapore's Avatamed Raises $1M in Seed Funding Avatamed will use the funds to expand into the Asia-Pacific market and set up a lab in Singapore to provide precision cancer drug screening services. SEngine Organoid Testing Leads to Treatment Change for Two Metastatic Colorectal Cancer Patients The researchers said their new study supports the clinical utility of their test, which combines genomic and drug screening analyses of organoids to guide cancer treatment. Glioblastoma Brain Tumor Treatment Strategies Stem From Pharmacogenomic Analysis By screening more than 1,500 drugs against patient-derived glioblastoma cells, researchers tracked down tumor alterations with apparent ties to proteasome inhibitor response. Jun 10, 2020 10x Genomics, MilliporeSigma Collaborate on CRISPR Screening Workflow Dec 5, 2019 High-Throughput Single-Cell Transcriptomics Assay Facilitates Compound Screens Premium Oct 2, 2019 SEngine Precision Medicine Raises $5.1M in Series A Financing Apr 10, 2019 Genome-Scale CRISPR Screening Helps Identify New Cancer Drug Targets Jan 15, 2019 Researchers Generate Catalog of Kinase Response to DNA-Damaging Agents Mar 7, 2018 French Researchers to Assess NovellusDx Assay for Ability to Predict Cancer Treatment Response Premium Oct 24, 2017 Cancer Drug Response Linked to Transcript Isoform Markers Jul 26, 2017 PLATE-Seq Method Adds Expression, Regulatory Insights to Cell Screens Premium Jul 11, 2017 SEngine Precision Medicine's Lab Garners CLIA Certification Jul 6, 2017 SEngine Precision Medicine Licenses Hutch Cancer Drug Screening Assay Dec 14, 2016 Duke Researchers Propose Combination Therapy for PIK3CA-Mutant Breast Cancer Nov 1, 2016 Agilent, PureHoney Technologies Partner to Develop New Mass Spec Applications Oct 1, 2015 Genomics Inks Drug Screening Deal With Biogen Nov 17, 2014 Horizon CombinatoRx to Profile Oncology Asset for Pharma Firm Sep 23, 2014 NIH Awards $17M for Next Phase of Tissue Chip for Drug Screening Program Jul 30, 2014 Broad Plans Large Sequencing Study to ID Personalized Drug Candidates for Psychiatric Disorders Premium Oct 8, 2013 Horizon Discovery to Support Blueprint Medicines' Cancer Research Platform Sep 11, 2013 Certara, C-Path Partner on Testing Models for Tuberculosis Drugs Sep 10, 2013 Bayer, Broad Aim to Develop Therapeutics Targeting Cancer Genome Alterations Aug 14, 2013 Institut Pasteur Korea, DNDi Partner in Neglected Diseases Screening Effort Load More Breaking News Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution Thermo Fisher, Oncocyte Ink Development, Comarketing Deal for Cancer IVDs Yourgene Health Enters Three-Year £5M Term Loan Facility The Scan And a Fourth? A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times. For Better Science Software A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports. Recommendation Explanations The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information. Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.